Question 1

Who is Martine A. Rothblatt?

Accepted Answer

Martine A. Rothblatt serves as Executive at UNITED THERAPEUTICS CORP (UTHR). They have executed 4994 insider transactions totaling $1.1B over their tenure at the company.

Question 2

What is Martine A. Rothblatt's role at UNITED THERAPEUTICS CORP?

Accepted Answer

Martine A. Rothblatt holds the position of Executive at UNITED THERAPEUTICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.

Question 3

Is Martine A. Rothblatt buying or selling UTHR stock?

Accepted Answer

Martine A. Rothblatt has shown a selling trading pattern, with $15.1M in total purchases and $1.0B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Martine A. Rothblatt's largest insider transactions?

Accepted Answer

The largest transaction by Martine A. Rothblatt was on Aug 16, 2024, when they sold $556.6K worth of UTHR shares. This transaction involved 1,734 shares at $320.97 per share.

Question 5

What is Martine A. Rothblatt's trading accuracy?

Accepted Answer

Martine A. Rothblatt has a Personal Accuracy Score of 100/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Martine A. Rothblatt associated with?

Accepted Answer

Martine A. Rothblatt has filed Form 4 transactions for 1 different company. Their primary association is with UNITED THERAPEUTICS CORP (UTHR), where they serve as Executive.

Question 7

How much UTHR stock does Martine A. Rothblatt own?

Accepted Answer

Martine A. Rothblatt currently owns 130 shares of UNITED THERAPEUTICS CORP (UTHR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Martine A. Rothblatt's equity in UNITED THERAPEUTICS CORP?

Accepted Answer

Martine A. Rothblatt's equity position in UNITED THERAPEUTICS CORP consists of 130 shares valued at approximately $0. As Executive, they have executed 4994 insider transactions, with $15.1M in purchases and $1.0B in sales.

Question 9

Where can I find Martine A. Rothblatt's SEC Form 4 filings?

Accepted Answer

All of Martine A. Rothblatt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Martine A. Rothblatt has 4994 Form 4 filings on record as an insider at UNITED THERAPEUTICS CORP.

Question 10

What is Martine A. Rothblatt's net worth from UTHR?

Accepted Answer

Based on their current UTHR stock holdings, Martine A. Rothblatt has equity worth approximately $0 in UNITED THERAPEUTICS CORP. This value is based on 130 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Aug 21, 2024	UTHR	$117.8K	Sale	340	$346.34	Planned
Aug 21, 2024	UTHR	$291.2K	Sale	837

Martine A. Rothblatt

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Martine A. Rothblatt Trading Summary

How Much UTHR Stock Does Martine A. Rothblatt Own?

Is Martine A. Rothblatt Buying or Selling UTHR?

Martine A. Rothblatt's Recent Stock Transactions

Frequently Asked Questions

Track Martine A. Rothblatt's Trades